Published in Int J Cancer on October 15, 1989
The structural basis of the functioning of bacteriorhodopsin: an overview. FEBS Lett (1979) 4.30
Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood (1992) 1.79
Humoral antibodies to methylcholanthrene sarcomata detected by a fluorescent technique. Nature (1965) 1.07
Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer (1993) 1.04
P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc Natl Acad Sci U S A (1996) 1.02
Recent findings in the structure-functional characteristics of bacteriorhodopsin. FEBS Lett (1977) 0.99
Products of limited proteolysis of bacteriorhodopsin generate a membrane potential. FEBS Lett (1978) 0.99
A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br J Cancer (1996) 0.98
Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol (1996) 0.96
Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Anal Chem (1991) 0.95
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells. Oncogene (1999) 0.93
The multidrug resistance phenotype confers immunological resistance. J Exp Med (1996) 0.92
Assessing plant response to ambient ozone: growth of ozone-sensitive loblolly pine seedlings treated with ethylenediurea or sodium erythorbate. Environ Pollut (2003) 0.92
Chromosomes in acute nonlymphocytic leukemia. Hum Genet (1986) 0.84
Overexpression of P-glycoprotein is associated with a decreased mitochondrial transmembrane potential in doxorubicin-selected K562 human leukemia cells. Int J Oncol (2000) 0.83
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate. Int J Cancer (1996) 0.82
[The effect of antibodies to gamma-globulin on the cytotoxic activity of immune lymphocytes in a culture of allogenic cells]. Biull Eksp Biol Med (1968) 0.81
H-2 antigens on murine leukemia cells and viruses. Int J Cancer (1972) 0.80
[Richter's syndrome: analysis of literature data and original observations]. Ter Arkh (1999) 0.80
[Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease]. Ter Arkh (2004) 0.79
Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia. Hum Genet (1981) 0.79
Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet (1999) 0.79
Markers of type D retroviruses in children with Burkitt's-type lymphoma. Immunol Lett (1996) 0.79
Chromosomal rearrangements with a common breakpoint at 6p23 in five cases of myeloid leukemia. Hum Genet (1983) 0.79
Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib. Biochemistry (Mosc) (2008) 0.79
[Toxoplasmosis in HIV infection: invasion reactivation criteria]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.78
[Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment]. Genetika (2008) 0.78
Chromosomes in acute leukemia. Hum Genet (1979) 0.78
Effects of physicochemical forms of phenazepam and Panavir on their action at ultra-low doses. Bull Exp Biol Med (2012) 0.77
Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncol Res (1998) 0.77
[Analysis of deletional damage in SMN1, SMN2, and NAIP genes in patients with spinal muscular atrophy in the northwestern region of Russia]. Genetika (2001) 0.77
[Stomach MALT-lymphoma with marked plasmocytic differentiation: a variant of Mott's cell tumor]. Arkh Patol (2004) 0.77
Chromosomal characteristics of malignant lymphoma. Hum Genet (1989) 0.77
Identification of a human erythroid cell surface antigen by monoclonal antibody HAE9. Exp Hematol (1987) 0.77
Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells. Biochemistry (Mosc) (2006) 0.76
Type D retrovirus specific sequences in lymphocytes of the children with Burkitt-type lymphoma and their parents. Immunol Lett (2001) 0.76
Ultrastructural criteria of malignancy of adrenal medullary tumor. Bull Exp Biol Med (2002) 0.76
[Differential diagnosis of Wegener's granulomatosis and extranodal NK/T-cell lymphoma, nasal type]. Ter Arkh (2012) 0.76
Cytotoxic effect of ricin A-chain conjugates containing monoclonal antibodies against human erythroid cells. Int J Immunopharmacol (1993) 0.75
[Expression of the human dystrophin gene in mdx mouse muscle fibers after transfection using liposomes and synthetic oligopeptides]. Genetika (1998) 0.75
[Hodgkin lymphoma with lymphoid predominance: differential diagnosis of nodular lymphoid predominance and classical variant]. Arkh Patol (2003) 0.75
Growth of normal and tumour haemopoietic cells on glass coverslips in peritoneal cavity of mice. II. Immunological identification of bone marrow colony-forming cells. Folia Biol (Praha) (1981) 0.75
Specific antigen of murine erythroblasts. Int J Cancer (1976) 0.75
[Angioimmunoblastic lymphadenopathy]. Ter Arkh (1979) 0.75
[Case of disseminated intravascular coagulation in lymphoblastic leukemia]. Klin Med (Mosk) (1978) 0.75
[Dermatofibrosarcoma protuberans]. Arkh Patol (1976) 0.75
[Differential diagnostic and prognostic significance of the activity of nucleolar organizer region in non-Hodgkin's malignant lymphoma]. Klin Lab Diagn (1997) 0.75
[A tumor-associated antigen of cervical cancer]. Eksp Onkol (1986) 0.75
[Mantle cell lymphoma]. Arkh Patol (2002) 0.75
[Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease]. Arkh Patol (2000) 0.75
[Pathology of mitosis in clinical oncomorphology]. Arkh Patol (1984) 0.75
[Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri]. Biull Eksp Biol Med (1992) 0.75
[Human leukemias studied with monoclonal antibodies to erythroid cells]. Eksp Onkol (1986) 0.75
[Immunohistochemical identification of hormonally-inactive tumors of the adrenal gland]. Vopr Onkol (2002) 0.75
[Use of immunological and molecular biological methods to diagnose cerebral toxoplasmosis in HIV infection]. Med Parazitol (Mosk) (2013) 0.75
[Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri]. Eksp Onkol (1988) 0.75
[Lung diseases in acute leukemia]. Klin Med (Mosk) (1973) 0.75
[Lymphoproliferative diseases of the orbit and appendages of the eye]. Arkh Patol (2001) 0.75
[Ultrastructural criteria of clinical prognosis in hormonally non-active adrenocortical tumors]. Vopr Onkol (2003) 0.75
[Humoral antibodies against methylcholanthrene-induced sarcomas]. Dokl Akad Nauk SSSR (1965) 0.75
[Prognostic importance of distinguishing lymphosarcoma variants by the WHO classification]. Gematol Transfuziol (1983) 0.75
[Unusual morphological picture of the blast crisis in chronic myeloleukemia]. Probl Gematol Pereliv Krovi (1980) 0.75
[Lymphoproliferative disorders and Sjögren's syndrome]. Ter Arkh (1978) 0.75
[Detection of erythroblast antigen in mice in tumor cells and in leukemia by means of immunofluorescence and immunoautoradiography]. Probl Gematol Pereliv Krovi (1979) 0.75
[Cytomorphological differentiation diagnosis and evaluation of p53mut, bcl-2, CD95 in peripheral B-cell small cell lymphomas]. Arkh Patol (2000) 0.75
[Changes in the variant of acute leukemia]. Ter Arkh (1984) 0.75
[Detection of group-specific antigen of mouse viruses in normal mice of high and low leukemic strains]. Biull Eksp Biol Med (1969) 0.75
[Enzymatic profile of spleen cells in murine amyloidosis]. Biull Eksp Biol Med (1971) 0.75
[Immunoblastic lymphosarcoma]. Arkh Patol (1982) 0.75
Blastomogenic activity of p-hydroxyphenyllactic acid in mice. Cancer Res (1975) 0.75
[Antibodies against interspecies erythrokaryocyte antigen in patients with partial red cell aplasia of the bone marrow]. Biull Eksp Biol Med (1980) 0.75
[Aminopeptidases in cells of non-Hodgkin's lymphoma of varying degrees of malignancy and in lymphogranulomatosis]. Arkh Patol (1997) 0.75
[Histochemical aspects of some stages of metabolism in fatty infiltration of the myocardium]. Arkh Patol (1965) 0.75
[Large-cell anaplastic lymphoma Ki-I]. Klin Lab Diagn (1997) 0.75
[Clinical aspects of lymphoblastic and prolymphocytic lymphosarcoma]. Ter Arkh (1978) 0.75
[Clinical morphological comparisons in neuroleukemia]. Klin Med (Mosk) (1976) 0.75
[Antigenic marker of human erythrokaryocytes similar to mouse erythroblastosis antigen]. Biull Eksp Biol Med (1978) 0.75
[Specific surface leukemic antigen and malignization of cells in mice of CC57BR strain innoculated with Mazurenko virus]. Biull Eksp Biol Med (1970) 0.75
[Mitotic regimen of different histological variants of lymphosarcoma]. Arkh Patol (1981) 0.75
[Lymphosarcoma with paraproteinemia]. Ter Arkh (1980) 0.75
[Main principles and diagnostic criteria of "Reevaluation of the European-American classification of lymphoid tumors"]. Arkh Patol (1997) 0.75
[Group and type specific antigens of Rauscher viral leukemia]. Vopr Onkol (1969) 0.75
[Immunocytochemical detection of antigen associated with squamous cell cancer of the cervix uteri in women]. Eksp Onkol (1990) 0.75
[Cell mechanisms that control Toxoplasma gondii dissemination in parenteral and oral infection]. Med Parazitol (Mosk) (2013) 0.75
[Hairy cell leukemia with specific omental involvement]. Ter Arkh (1996) 0.75
[MALT gastric lymphoma--principles of morphological diagnosis]. Arkh Patol (2003) 0.75
Reactivity of anti-macrophage monoclonal antibody D11 in human leukemia and malignant lymphoma. Int J Cancer (1996) 0.75
[Myeloma disease developing into acute plasma cell leukemia]. Probl Gematol Pereliv Krovi (1976) 0.75
[Clinico-morphological characteristics of prolymphocytic variants of lymphosarcoma]. Ter Arkh (1981) 0.75
[Ultrastructural characteristics of the lymph node cells in lympho- and reticulosarcomas]. Arkh Patol (1977) 0.75
[Expression of argyrophilic proteins from the nucleolar organizer regions as an index of maturity degree of benign and malignant adrenal tumors]. Arkh Patol (2004) 0.75
[Angiofollicular hyperplasia of the neck lymph nodes]. Vopr Onkol (1982) 0.75
[Diagnosis of chronic lymphoid leukemia (an immunomorphological study)]. Arkh Patol (2003) 0.75
[Morphological manifestations of large cell anaplastic Ki1(CD30)-positive lymphoma in children]. Arkh Patol (2000) 0.75
[Immunohistochemical study of a flat epithelial antigen and prospects for using it as a marker for squamous cell carcinoma]. Biull Eksp Biol Med (1995) 0.75
[Results of the polychemotherapy of different variants of lymphosarcomas based on the World Health Organization classification]. Gematol Transfuziol (1983) 0.75
[Ultrastructure of the lymph node cells in hyperplasia and lymphosarcoma]. Probl Gematol Pereliv Krovi (1977) 0.75
[Angiofollicular hyperplasia of the retroperitoneal lymph nodes (two cases)]. Vopr Onkol (1983) 0.75